Projects enabling the rapid translation of research to quickly and effectively act on health threats such as cancer and infectious disease.
Researchers from the University of Melbourne and Peter Doherty Institute are leading the first flagship genomic innovation projects, leading the way for the future pipeline of commercially focused genomics innovation projects to utilise the partnership's infrastructure and expertise. The Cancer of Low Survival and Unmet Need health systems innovation project aims to improve diagnosis and provide more targeted and effective treatments for cancers of unmet need.
Cancer of Low Survival and Unmet Need Initiative
Sequencing genomes of the most challenging cancer cases in real-time for personalised clinical treatment and care.
ID Predict: A genomics-focused platform for treatment of COVID-19 and other infectious diseases
Genomics platform to understand the varied types of disease progression of patients with COVID-19, which will help to identify what treatment is best suited to individual patients.
Cancer Liquid Biopsy: Non-invasive blood-based monitoring for cancer
Using genomic tools for detection and monitoring of circulating tumour DNA (ctDNA) in patient blood samples to enable cancer detection, surveillance and recurrence screening